Divi's Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : DIVISLAB
NIFTY : Nifty Next 50
NIFTY SECTOR : Nifty Pharma

About Company

Divi’s Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generics, the Company, through its custom synthesis, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.  The Company has two wholly owned subsidiaries which are Divis Laboratories (USA) Inc in USA and Divi’s Laboratories Europe AG in Switzerland; engaged in marketing/distribution of nutraceutical ingredients used in the food, beverage, dietary supplement, feed and pet food industries providing a greater reach to customers within these regions.

Market Cap. ₹ 151,583 Cr.

52 Week - High/Low ₹ 7,072/4,616

P/E Ratio 64.77

P/B Ratio 10.18

Enterprise Value ₹ 148,396 Cr.

ROE % 15.57

RSI Value 30.57

EMA 50 6134.97

EMA 200 6024.97

Market Cap. ₹ 151,583 Cr.

52 Week - High/Low ₹ 7,072/4,616

P/E Ratio 65.61

P/B Ratio 10.13

Enterprise Value ₹ 148,368 Cr.

ROE % 15.35

RSI Value 30.57

EMA 50 6134.97

EMA 200 6024.97

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us